CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $1,063,000 | +3.9% | 17,167 | -8.0% | 0.00% | 0.0% |
Q3 2020 | $1,023,000 | +17.6% | 18,663 | +23.4% | 0.00% | 0.0% |
Q2 2020 | $870,000 | +90.8% | 15,124 | +33.3% | 0.00% | +50.0% |
Q1 2020 | $456,000 | +41.2% | 11,344 | +38.7% | 0.00% | +100.0% |
Q4 2019 | $323,000 | +226.3% | 8,179 | -43.7% | 0.00% | – |
Q3 2019 | $99,000 | +20.7% | 14,531 | +65.2% | 0.00% | – |
Q2 2019 | $82,000 | +34.4% | 8,796 | -15.2% | 0.00% | -100.0% |
Q2 2014 | $61,000 | -74.2% | 10,374 | -70.9% | 0.00% | -66.7% |
Q1 2014 | $236,000 | +263.1% | 35,619 | +219.7% | 0.00% | +200.0% |
Q4 2013 | $65,000 | – | 11,141 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |